This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Drug Topics : What are the primary contributors to stress or frustration among pharmacy technicians today? I think one of the biggest resources that we think of in pharmacy specifically is, yes, manpower, yes people, but also time. I would say some of those are some of the biggest.
Pharmacy technicians play a vital role in the success of communitypharmacies. Watterson was an author on a recent study published in the Journal of the American Pharmacists Association , which investigated the well-being of communitypharmacy technicians. “I I think, especially in the community setting, 99.9%
A narrative literature review: Communitypharmacy technician well-being and its implications. J Am Pharm Assoc (2003). References 1. Fick G, Osei J, Kim S, et al. 2025 May 9:102419. doi: 10.1016/j.japh.2025.102419. 2025.102419. Epub ahead of print. PMID: 40349976.
Similar interventions in the communitypharmacy setting also demonstrated significant value, with pharmacists identifying unaddressed issues with mood in nearly two-thirds of patients and increasing the uptake of naloxone. Implementation and assessment of a pilot, communitypharmacy-based, opioid pain medication management program.
Implementation and evaluation of social determinants of health practice models within communitypharmacy. J Am Pharm Assoc (2003). Am J Health Syst Pharm. 2019;76(4):251-253. doi:10.1093/ajhp/zxy040 13. Foster AA, Daly CJ, Logan T, et al. 2022;62(4):1407-1416.doi:10.1016/j.japh.2022.02.005 doi:10.1016/j.japh.2022.02.005
Bush’s Medicare Modernization Act (MMA) of 2003, and with it drug coverage for tens of millions of Medicare enrollees for the first time in program history. 2 About the Author Troy Trygstad, PharmD, PhD, MBA, is the executive director of CPESN USA, a clinically integrated network of more than 3500 participating pharmacies.
According to a study published in the journal Pharmacy , community pharmacists are well-positioned to increase the availability of mindfulness-based interventions because of their higher accessibility compared to primary care providers, particularly in rural areas. Pharmacy (Basel). J Am Pharm Assoc (2003). 2018.10.017.
J Am Pharm Assoc (2003). The effect of communitypharmacy-based interventions on patient health outcomes: a systematic review. Fera T, Bluml BM, Ellis WM. Diabetes Ten City Challenge: final economic and clinical results. 2009;49(3):383-391. doi:10.1331/JAPhA.2009.09015 Med Care Res Rev. 2013;70(3):235-266.
A study published in 2022 found “significant price variation in communitypharmacies,” and a Consumer Reports survey showed prices can vary by hundreds of dollars between pharmacies—even ones in the same town. Without help from a health insurance plan, Medicare Part D, or Medicaid, the drug’s list price is $1,069.08
Just this year, the FDA approved Jesduvroq tablets (daprodustat) as the first oral treatment for anemia caused by chronic kidney disease, for adults who have been receiving dialysis for at least four months. [58] 58] FDA approves first oral treatment for anemia caused by chronic kidney disease for adults on dialysis. September 2020.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content